Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Monoclonal APC Primary Antibody for IF, WB - ABIN393899
Jaulin, Kreitzer: KIF17 stabilizes microtubules and contributes to epithelial morphogenesis by acting at MT plus ends with EB1 and APC. in The Journal of cell biology 2010
Show all 5 references for ABIN393899
Human Monoclonal APC Primary Antibody for IHC (fro), IP - ABIN152091
Abutaily, Collins, Roche: Cadherins, catenins and APC in pleural malignant mesothelioma. in The Journal of pathology 2003
Show all 2 references for ABIN152091
Mouse (Murine) Monoclonal APC Primary Antibody for EIA, IF - ABIN1105399
Hendriksen, Jansen, Brown, van der Velde, van Ham, Galjart, Offerhaus, Fagotto, Fornerod: Plasma membrane recruitment of dephosphorylated beta-catenin upon activation of the Wnt pathway. in Journal of cell science 2008
Human Polyclonal APC Primary Antibody for ICC, IF - ABIN4280975
Liu, Tackmann, Yang, Zhang: Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis. in Oncogene 2016
APC haploinsufficiency coupled with p53 (show TP53 Antibodies) deletion resulted in the development of a distinct type of pancreatic premalignant precursors, mucinous cystic neoplasms (MCNs)
Gasdermin C is upregulated by inactivation of Tgfbr2 (show TGFBR2 Antibodies) in the presence of mutated Apc, promoting colorectal cancer cell proliferation.
By sequencing Apc and Ctnnb1 (show CTNNB1 Antibodies) genes, we found that most PhIP (show PHIP Antibodies)-induced small intestinal tumors in obese mice carried only a single heterozygous mutation in Apc . Our findings demonstrate that PhIP (show PHIP Antibodies)-induced small intestinal carcinogenesis in hCYP1A-db/db (show LEPR Antibodies) mice is promoted by obesity and involves Apc mutation and inactivation by DNA hypermethylation
Elevated coexpression of KITENIN (show Vangl1 Antibodies) and ErbB4 (show ERBB4 Antibodies)-CYT (show CYGB Antibodies)-2 promotes the transition of colon adenoma to adenocarcinoma within an APC loss-associated tumor microenvironment
The activation of canonical Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling by deletion of Apc in cardiomyocytes led to ventricular hyperplasia.
demonstrated that despite having both Kras and Pik3ca (show PIK3CA Antibodies) mutations at the time of tumor initiation from loss of APC
Suggest that the early activation of Hsf1 (show HSF1 Antibodies) dependent cell stress pathway by mono-allelic mutations in APC can affect cell programming in a way that contributes to cancer onset.
Adenomatous polyposis coli mutation leads to myopia development in mice.
findings indicate Ctnnb1 (show CTNNB1 Antibodies) gene dose exerts tissue-specific differences in Apc mutation-instigated tumorigenesis
Microsatellite instability in the Apc gene does not significantly affect chlorinated water-induced colonic tumorigenesis.
Nine patients with 21- approximately 100 colorectal adenomas (50%) and the two positive controls, showed somatic mosaicism, with identical APC variants in adenomas tested.
These result suggested that miR (show MLXIP Antibodies)-590-3p can promote osteogenic differentiation via suppressing APC expression and stabilizing beta-catenin (show CTNNB1 Antibodies).
The present findings indicate epigenetic silencing of APC in advanced gallbladder cancer (GBC). The methylation pattern, followed by expression analysis of APC may be suggested for diagnostic, prognostic and therapeutic purposes in GBC in future
miR (show MLXIP Antibodies)-106a-5p is involved in the invasive behavior of glioblastoma cells and by targeting APC and activating Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) pathway.
Point Mutations in Exon 1B of APC Reveal Similar mutations in APC promoter 1B occur in rare families with familial adenomatous polyposis
Studies suggest that both loss of tumor suppressive function and gain of function of APC mutants play critical roles in colorectal cancers (CRC (show CALR Antibodies)) tumorigenesis.
Loss of heterozygosity of TP53 (show TP53 Antibodies), P16 (show CDKN2A Antibodies), SMAD4 (show SMAD4 Antibodies) and APC genes was observed in esophageal adenocarcinoma.
miR (show MLXIP Antibodies)-582-5P was upregulated in the colorectal cancer specimens and cell lines and targeted the 3' untranslated region of APC directly.
Loss of APC expression through methylation of its promoter is a widespread phenomenon in Wnt (show WNT2 Antibodies)//beta-catenin (show CTNNB1 Antibodies) activated tumors.
the Amer2 (show AMER2 Antibodies)-EB1 (show MAPRE1 Antibodies)-APC complex regulates cell migration by altering microtubule stability.
Data show that importin-beta (show KPNB1 Antibodies) binds to Apc and negatively regulates the MT-assembly and spindle-promoting activity of Apc in a Ran-regulatable manner.
APC and Axin (show AXIN1 Antibodies) are involved in the Wnt (show WNT2 Antibodies) pathway
depletion of APC from cystostatic factor (CSF (show CSF2 Antibodies)) Xenopus extracts leads to a decrease in microtubule density and changes in tubulin (show TUBB Antibodies) distribution in spindles and asters formed in such extracts
An interaction of tumor-associated N-terminal APC fragments (N-APC) with Mad2 (show MAD2L1 Antibodies), an essential mitotic checkpoint (show BUB3 Antibodies) protein, providing a direct molecular support for linking APC mutations to the generation of chromosome instability, is reported.
This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product.
adenomatosis polyposis coli
, adenomatous polyposis coli protein
, multiple intestinal neoplasia
, adenomatosis polyposis coli tumor suppressor
, deleted in polyposis 2.5
, protein phosphatase 1, regulatory subunit 46
, adenomatous polyposis coli homolog